Body mass index (BMI [calculated as weight in kilograms divided by height in meters squared]) is positively associated with the risk of colorectal cancer (CRC).
1-9 For that reason, investigators have hypothesized that being overweight or obese leads to worse CRC prognosis. However, though previous studies have shown an apparently elevated mortality risk in patients who are class II or III obese (BMI ≥35),
10-12 associations of class I obesity (BMI 30 to <35) and survival are mixed; some studies show a higher mortality risk
6,10,13-16 and others show no higher
17 mortality risk or a possible lower
18 mortality risk, depending in part on when BMI is measured relative to diagnosis. Patients who have CRC and are overweight or obese have shown lower mortality risks
11,18 compared with patients who are normal weight or underweight when BMI is measured following diagnosis, but concerns are that the obesity paradox could reflect sample selection bias, reverse causality, and/or collider bias.
19-21 We sought to employ methods to overcome these concerns in our evaluation of the effect of BMI on postdiagnosis mortality.